DE BACKER MARIANNE (Chief Executive Officer) reported 2 transactions at VIR BIOTECHNOLOGY, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/30/2026ACC: 0001628280-26-029041
DirectorOfficer· Chief Executive Officer
Since Feb 2026
0.00
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
233.53K acquired · 233.53K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−233.53K
Price / share
—
Trade value
—
% of position
24.6%
4/29/2026
948.14K→714.61K
Common Stock
Indirect
Shares
+233.53K
Price / share
—
Trade value
—
% of position
439.6%
4/29/2026
53.12K→286.65K
Total
Net shares
+0.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/29/2026 | J · J | −233.53K | — | — | 24.6% | 948.14K | 714.61K |
| Common Stock Indirect | 4/29/2026 | J · J | +233.53K | — | — | 439.6% | 53.12K | 286.65K |
| Total | +0.00 | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported